\
&
Contact us
\
&
Contact us
This was 6 months ago
Locationonline
ProgrammesHORIZON-EIE-2026-01-CONNECT-01: European network of national competence centers for innovation procurement
HORIZON-EIE-2026-01-CONNECT-02: Expanding Investment Ecosystems
HORIZON-EIE-2026-01-CONNECT-03: Scaling up deep tech ecosystems
The calls, launched under the Horizon Europe - Work Programme 2025 - 10. European Innovation Ecosystems (EIE), will be open until 20 January 2026, 17:00 CET.
For any additional information, please check the European Innovation Ecosystems webpage or contact EISMEA-EU-ECOSYSTEMS@ec.europa.eu.
Details and registration can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
